RNA-containing adenovirus/polyethylenimine transfer complexes effectivety transduce dendritic cells and induce antigen-specific T cell responses

被引:6
作者
Gust, TC
Diebold, SS
Cotten, M
Zenke, M
机构
[1] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany
[2] Canc Res UK, London WC2A 3PX, England
[3] Axxima Pharmaceut, D-82152 Martinsried, Germany
关键词
dendritic cells; gene delivery; Ad/PEI transfection; ovalbumin; T cell activation;
D O I
10.1002/jgm.492
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background Dendritic cells (DCs) are the most potent antigen-presenting cells in initiating primary immune responses. Given the unique properties of DCs, gene-modified DCs represent a particularly attractive approach for immunotherapy of diseases such as cancer. Methods Gene-modified DCs were obtained by a receptor-mediated gene delivery system using adenovirus (Ad) particles as ligand and RNA or DNA condensed by polyethylenimine (PEI). In vitro transcribed polyadenylated or non-polyadenylated RNA was used. RNA-transduced DCs were generated expressing chicken ovalbumin (OVA) or chimeric constructs thereof, and compared with DNA-transduced DCs. Results Ad/PEI transfection complexes efficiently delivered RNA into DCs. Such RNA-transduced DCs induced OVA-specific T cell responses more effectively than DNA-transduced DCs. Furthermore, DCs transduced with polyadenylated RNA were more potent in stimulating CD4(+) and CD8(+) T cell responses than DCs transduced with non-polyadenylated RNA and this was particularly important for CD4(+) T cell responses. Conclusions Ad/PEI/RNA transfection is an efficient means for generating RNA-transduced DCs and for stimulating antigen-specific T cell responses. Polyadenylation of RNA enhances CD8(+) T cell responses and is essential for CD4(+) T cell responses. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:464 / 470
页数:7
相关论文
共 52 条
  • [1] Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors
    Ashley, DM
    Faiola, B
    Nair, S
    Hale, LP
    Bigner, DD
    Gilboa, E
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) : 1177 - 1182
  • [2] Delivery of bacterial artificial chromosomes into mammalian cells with psoralen-inactivated adenovirus carrier
    Baker, A
    Cotten, M
    [J]. NUCLEIC ACIDS RESEARCH, 1997, 25 (10) : 1950 - 1956
  • [3] Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery
    Baker, A
    Saltik, M
    Lehrmann, H
    Killisch, I
    Mautner, V
    Lamm, G
    Christofori, G
    Cotten, M
    [J]. GENE THERAPY, 1997, 4 (08) : 773 - 782
  • [4] Immunobiology of dendritic cells
    Banchereau, J
    Briere, F
    Caux, C
    Davoust, J
    Lebecque, S
    Liu, YT
    Pulendran, B
    Palucka, K
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 767 - +
  • [5] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [6] Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells
    Bettinger, T
    Carlisle, RC
    Read, ML
    Ogris, M
    Seymour, LW
    [J]. NUCLEIC ACIDS RESEARCH, 2001, 29 (18) : 3882 - 3891
  • [7] Boczkowski D, 2000, CANCER RES, V60, P1028
  • [8] A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE
    BOUSSIF, O
    LEZOUALCH, F
    ZANTA, MA
    MERGNY, MD
    SCHERMAN, D
    DEMENEIX, B
    BEHR, JP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) : 7297 - 7301
  • [9] REDUNDANT CONTROL OF ADENOVIRUS LATE GENE-EXPRESSION BY EARLY REGION-4
    BRIDGE, E
    KETNER, G
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (02) : 631 - 638
  • [10] Cell cycle dependence of gene transfer by lipoplex polyplex and recombinant adenovirus
    Brunner, S
    Sauer, T
    Carotta, S
    Cotten, M
    Saltik, M
    Wagner, E
    [J]. GENE THERAPY, 2000, 7 (05) : 401 - 407